98%
921
2 minutes
20
Background: Schwannoma is a common benign tumor. Most schwannomas are sporadic, but approximately 5% of schwannomas are multifocal. Schwannomas are sometimes present in a skip-like pattern on a single continuous peripheral nerve (Multiple schwannomas scattered on a single peripheral nerve: MSSPN). In this study, we present the clinical characteristics of MSSPN in the limbs and propose a treatment strategy based on treatment outcomes.
Methods: The medical records of 918 patients diagnosed with schwannoma in the limbs were retrospectively reviewed. Among these cases, multiple schwannomas occurring in a single peripheral nerve and spaced more than 1 cm apart were defined as MSSPN. We investigated the clinical characteristics and surgical outcomes.
Results: Seven patients with MSSPN in the limbs were identified, which represented 0.8% of all cases. There were six females and one male, and the mean age was 50 years. The location of MSSPN was the upper limbs in two cases and the lower limbs in five cases. After surgery, among the five cases in which all tumors were enucleated, neurological symptoms worsened in 4 cases, all of which involved deep nerve tumors. The one case among these five cases in which neurological symptoms improved involved a superficial subcutaneous tumor. Neurological symptoms improved in both of the two cases in which only the tumor causing the main complaint was enucleated; both cases involved deep nerve tumors. The average postoperative follow-up was 8 months, and no cases required reoperation or complained of recurrence.
Conclusion: This is the first study to address the surgical strategies of multiple schwannomas occurring in a skip-like pattern on a single peripheral nerve. In surgery for MSSPN, selective enucleation of only the most symptomatic tumors may be effective in preventing the worsening of symptoms after surgery.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12145580 | PMC |
http://dx.doi.org/10.1186/s12893-025-02966-x | DOI Listing |
Pain Med Case Rep
October 2023
Adena Medical Center, Chilicothe, OH.
Background: Peripheral nerve stimulation has been available for many years, yet there is relatively little information available regarding stimulation of many of the large sensory and mixed nerves.
Case Report: A 42-year-old woman presented to the clinic for a 10-year history of intractable left upper extremity and forearm pain following a motor vehicle accident requiring skin grafting. Based on the patient's failure of more conservative therapy, a shared decision was made to pursue opioid sparing interventional modalities.
Pain Med Case Rep
September 2023
Department of Anesthesiology and Critical Care Medicine, Memorial Sloan Kettering Cancer Center, New York, NY.
Background: Management of cancer-related pain is an important public health issue, with significant impacts on patient quality of life. Interventional techniques for pain relief, such as perineural catheters, are widespread in clinical practice, allowing the reduction of reliance on morphine. However, their use can result in difficulties, such as catheter dislodgement, leading to a loss of efficacy.
View Article and Find Full Text PDFPain Med Case Rep
September 2023
USC University Hospital: Keck Hospital of USC, Los Angeles, CA.
Background: Peripheral nerve stimulators (PNS) are currently used for refractory cases of neuralgia, and are associated with single manufacturer use. This is the first case report describing the novel scenario where a patient received 2 neuromodulation devices from 2 different manufacturers.
Case Report: We present a 32-year-old woman with spinal muscle atrophy type 2 who received a permanent PNS implant for chronic neuralgia.
Pain Med Case Rep
September 2023
Baylor College of Medicine, H. Ben Taub Department of Physical Medicine and Rehabilitation, Houston, TX.
Background: Cluneal neuralgia is increasingly becoming recognized as an etiology of low back pain. The majority of the literature on cluneal nerve interventions describes modalities targeting the superior cluneal nerves with little emphasis on the middle cluneal nerves.
Case Report: A 21-year-old woman with a medical history of congenital myelomeningocele with tethered cord at L5-S1, status post 3 decompressive releases, presented to the clinic with chronic low back pain and associated sacroiliac paresthesia.
Sci Transl Med
September 2025
Roche Pharma Research and Early Development, Pharmaceutical Sciences, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd., 4070 Basel, Switzerland.
Oligodendrocytes, the myelinating cells of the central nervous system (CNS), are essential for the formation of myelin sheaths and pivotal for maintaining axonal integrity and conduction. Disruption of these cells and the myelin sheaths they produce is a hallmark of demyelinating conditions like multiple sclerosis or those resulting from certain drug side effects, leading to profound neurological impairments. In this study, we created a human brain organoid comprising neurons, astrocytes, and myelinating oligodendrocytes.
View Article and Find Full Text PDF